X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
LPT CBD (cannabinoid) is a loaded liposome platform facilitating exact dosing and the prolonged and controlled release of CBD into the blood stream. It is being evaluated for the treatment for chronic pain management.
Lead Product(s): Cannabidiol
Therapeutic Area: Neurology Product Name: LPT-CBD
Highest Development Status: PreclinicalProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable April 22, 2024
Details:
The agreement facilitates Innocan to initiate the FDA approval process for its liposome CBD platform (LPT-CBD), facilitating prolonged and controlled release of CBD into the blood stream. It is being evaluated for the treatment of epilepsy and for pain management.
Lead Product(s): Cannabidiol
Therapeutic Area: Neurology Product Name: LPT-CBD
Highest Development Status: PreclinicalProduct Type: Small molecule
Partner/Sponsor/Collaborator: Hebrew University
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement March 25, 2024
Details:
LPT-CBD (cannabidiol) is a CB1 receptor negative allosteric modulator, which is being evaluated for the treatment of patients suffering from neurological diseases.
Lead Product(s): Cannabidiol
Therapeutic Area: Neurology Product Name: LPT-CBD
Highest Development Status: PreclinicalProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable March 05, 2024
Details:
LPT CBD (cannabinoid) is a loaded liposome platform facilitating exact dosing and the prolonged and controlled release of CBD into the blood stream. It is being evaluated for the treatment of epilepsy and for pain management.
Lead Product(s): Cannabidiol
Therapeutic Area: Neurology Product Name: LPT-CBD
Highest Development Status: PreclinicalProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable February 26, 2024
Details:
Cannabidiol is a CB1 receptor negative allosteric modulator (NAM), which is being evaluated in preclinical studies for the treatment of Pain.
Lead Product(s): Cannabidiol
Therapeutic Area: Neurology Product Name: Undisclosed
Highest Development Status: PreclinicalProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable October 23, 2023
Details:
The Company intends to use the net proceeds to fund the Company's pre-investigational new drug meeting regarding the human application of the Company's products, including Cannabidiol.
Lead Product(s): Cannabidiol
Therapeutic Area: Immunology Product Name: Undisclosed
Highest Development Status: UndisclosedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Research Capital Corporation
Deal Size: $1.6 million Upfront Cash: Undisclosed
Deal Type: Private Placement October 20, 2023
Details:
The Company intends to use the net proceeds from the Offering to fund the Company's pre-investigational new drug meeting with the United States FDA regarding the human application and expansion of the Company's derma-cosmetic product distribution.
Lead Product(s): Cannabidiol,Menthol,Camphor
Therapeutic Area: Neurology Product Name: Relief & Go
Highest Development Status: ApprovedProduct Type: Small molecule
Partner/Sponsor/Collaborator: Research Capital Corporation
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Private Placement October 12, 2023
Details:
Cannabidiol is a topical CB1 receptor negative allosteric modulator (NAM), which is being evaluated in phase 1 clinical studies for the treatment of Diabetic Foot.
Lead Product(s): Cannabidiol
Therapeutic Area: Podiatry Product Name: Undisclosed
Highest Development Status: PreclinicalProduct Type: Small molecule
Partner/Sponsor/Collaborator: Not Applicable
Deal Size: Not Applicable Upfront Cash: Not Applicable
Deal Type: Not Applicable August 15, 2023
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] 
Market Place
